Publication | Closed Access
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial
38
Citations
20
References
2020
Year
Surgical OncologyOncologyHealth EconomicsCancer ManagementEconomic AnalysisOligometastatic CancerPharmacoeconomicsCancer RegistrationSurgeryCost EffectivenessCancer TreatmentSabr-comet Randomized TrialMedicineCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1